TCBP Stock Price | TC BioPharm Holdings PLC P/E, Revenue, EPS, & Forecasts

TC BioPharm Holdings PLC • TCBP

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About TC BioPharm Holdings PLC

Ticker

TCBP

Trading on

PINK

ISIN

US87807D1037

Industry

Biotechnology

Sector

Healthcare

CEO

Bryan Leland Kobel

Headquarters

Maxim 1, Motherwell, undefined, United Kingdom, ML1 4WR

Employees

Website

https://tcbiopharm.com

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Metrics

BasicAdvanced

Market cap

$0.3M

P/E ratio

EPS

-$4,794.42

Dividend Yield

0.00%

Beta

0.01

Forward P/E ratio

EBIDTA

$-11.3M

Ex dividend date

Price & volume

Market cap

$0.3M

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

0.51

Price to book

0.09

Earnings

EPS

-$4,794.42

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-11.3M

Revenues (TTM)

$2.9M

Revenues per share (TTM)

$29.64

Technicals

Beta

0.01

52-week High

$20.00

52-week Low

$0.50

50-day moving average

$1.91

200-day moving average

$41.56

Short ratio

0.11

Short %

10.22%

Management effectiveness

ROE (TTM)

-577.04%

ROA (TTM)

-98.20%

Profit margin

0.00%

Gross profit margin

$3.8M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

-86.80%

Quarterly revenue growth (YoY)

188.60%

Share stats

Outstanding Shares

0.5M

Float

98.9M

Insiders %

Institutions %

0.71%

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$9.37

Q4 • 21Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-2M

-∞%

Q2 • 24

$-2M

0.00%

Q3 • 24

NaN%

-0.00%

0.00%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$6.9M

$4.9M

70.83%

Q2 • 24

$6.9M

$4.9M

70.83%

Q3 • 24

0.00%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-2.7M

$-0M

$2.8M

$-2.8M

Q2 • 24

$-2.7M

$2.8M

$-2.8M

Q3 • 24

0.00%

-0.00%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a TC BioPharm Holdings PLC share?

TC BioPharm Holdings PLC shares are currently traded for undefined per share.

How many shares does TC BioPharm Holdings PLC have?

TC BioPharm Holdings PLC currently has 0.5M shares.

Does TC BioPharm Holdings PLC pay dividends?

No, TC BioPharm Holdings PLC doesn't pay dividends.

What is TC BioPharm Holdings PLC 52 week high?

TC BioPharm Holdings PLC 52 week high is $20.00.

What is TC BioPharm Holdings PLC 52 week low?

TC BioPharm Holdings PLC 52 week low is $0.50.

What is the 200-day moving average of TC BioPharm Holdings PLC?

TC BioPharm Holdings PLC 200-day moving average is $41.56.

Who is TC BioPharm Holdings PLC CEO?

The CEO of TC BioPharm Holdings PLC is Bryan Leland Kobel.

How many employees TC BioPharm Holdings PLC has?

TC BioPharm Holdings PLC has 41 employees.

What is the market cap of TC BioPharm Holdings PLC?

The market cap of TC BioPharm Holdings PLC is $0.3M.

What is the P/E of TC BioPharm Holdings PLC?

The current P/E of TC BioPharm Holdings PLC is null.

What is the EPS of TC BioPharm Holdings PLC?

The EPS of TC BioPharm Holdings PLC is -$4,794.42.

What is the PEG Ratio of TC BioPharm Holdings PLC?

The PEG Ratio of TC BioPharm Holdings PLC is null.